INFECTION PREVENTION Sponsored by
hypochlorous at a low ppm doesn’t cause lung irritation. “Because COVID-19 is a respiratory illness, using disinfectants that don’t exasperate respiratory irritation is crucial,” said Guest. “In addition, a lot of people have sustainability goals in healthcare, so when you can produce products onsite, it helps achieve these goals by eliminat- ing unnecessary deliver- ies and the disposal of cardboard and hazardous plastic waste. Producing disinfectant onsite also eliminates the need to pro- cure, receive and store products, thus alleviating time-consuming tasks in materials management and other departments.”
Application options Proper application of disinfectants is key to their effectiveness, and there are a variety of options on the market beyond the standard “spray and wipe” method. David St. Clair, Chairman and CFO, Halosil International, comments on a few of the available solutions. “Certain solutions, such as spray
and wipe products, require manual application, which increases risks for cleaning staff and introduces the potential of missing pathogens in hard-to-reach areas,” said St. Clair. “Electrostatic guns require a human attendant to operate, increasing
the risk of exposure for EVS personnel to both pathogens and chemicals as well as introducing a greater risk of human error in disinfectant application. In addition, they require surfaces to become wet, which can damage electronics and leave a sticky residue.” “Other solutions, such as
dry foggers, are dry by their very nature and can operate entirely in touchless mode, reaching all the nooks and crannies of an environment without leaving a sticky or wet residue,” St. Clair added. “This limits labor costs and exposure of clean- ing staff all while mitigating concerns that disinfectants will damage costly equip- ment.”
R-Water TK60 Healthcare-Grade Disinfectant
The Halo Disinfection System from Halosil International
With regard to UV disin- fectants, Dr. Ashish Mathur, Ph.D., Vice President of Innovation and Technology, Ultraviolet Devices (UVDI), says, like manual disinfec- tants, the effectiveness in use can be evaluated by multiple techniques, including before- and-after environmental con- tamination studies, culturing and surveillance. However, given the lack of consistent industry standards for UV device effi ciency, it is impor- tant for healthcare personnel to conduct UV device-specifi c due diligence of effectiveness
prior to adoption and use. He offers four
criteria for healthcare facilities when evaluat- ing and selecting a proven UV device. “First, is claimed device
effi cacy validated by inde- pendent, third party labo- ratory testing? Second, are the claims for whole room disinfection sup- ported by testing at real-
Ashish Mathur
world distances that correlate to whole room disinfection? Third, has the device’s effectiveness been proven in peer-reviewed published clinical studies? Last, does the manufacturer have a proven methodol- ogy to confi rm that a germicidal dose has reached a target surface? Addressing these four simple questions can help healthcare professionals understand if a UV device is truly effective.” Synexis has developed a biodefense sys-
tem that uses patented technology to create the gas form of hydrogen peroxide, called Dry Hydrogen Peroxide or DHP. Kari L. Love, RN, MS, CIC, FAPIC, Program Direc- tor Infection Prevention, Offi ce of Quality,
Synexis DHP technology
don’t just deactivate pathogens...
26 November 2020 • HEALTHCARE PURCHASING NEWS •
hpnonline.com 2011HPN_activTekHealth 1
10/12/20 1:09 PM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66
